FDA NDC Directory · JSON-LD · Markdown

Oseltamivir Phosphate

NDC 0093-8180 · HUMAN PRESCRIPTION DRUG · POWDER, FOR SUSPENSION

Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA211125
Dosage form / routePOWDER, FOR SUSPENSION · ORAL
Active ingredientsOSELTAMIVIR PHOSPHATE (6 mg/mL)
Marketing started20190710
Package count1

External sources

Source: openFDA. Public-domain (CC0).